Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
Autor: | Michel, Pierre, Boige, Valerie, Andre, Thierry, Aparicio, Thomas, Bachet, Jean Baptiste, Dahan, Laetitia, Guimbaud, Rosine, Lepage, Côme, Manfredi, Sylvain, Tougeron, David, Taieb, Julien, Selves, Janick, Le Malicot, Karine, Di Fiore, Frederic, Maillard, Emilie |
---|---|
Zdroj: | In Digestive and Liver Disease March 2018 50(3):305-307 |
Databáze: | ScienceDirect |
Externí odkaz: |